GDF2 and pulmonary arterial hypertension: Further genetic mutations identified in PAH cases involve the growth differentiation factor 2 (GDF2) gene, encoding for the bone morphogenetic protein 9 (BMP9), which plays a pivotal role in preventing apoptosis and enhancing monolayer integrity of endothelial cells in lung vasculature [42].